Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - August 20, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 19 of 19     Go To Page:

8/20/17 - Regional GlaxoSmithKline chief reveals how new pharma is changing Gulf health care [Arab News (Saudi Arabia)]
What the critics call big pharma has had an image problem in recent years, and Andrew Miles, the executive in charge of the global health care company GlaxoSmithKline s business in the Gulf, thinks he knows how to resolve it. Choice of medication should be a clinical choice, rather than being based on some potential conflict of interest
8/19/17 - President Trump Signs OTC Hearing Aid Legislation into Law
On Friday, August 18, President Donald Trump signed into law today the Food and Drug Administration Reauthorization Act of 2017, legislation that includes the Over the Counter Hearing Aid Act designed to provide greater public accessibility and affordability with over-the-counter (OTC) hearing aids. FDA will now be charged with creating and regula
8/19/17 - Q: My son has started teething
Q: My son has started teething, and I'd like to ease his discomfort. However, tests recently performed by the Food and Drug Administration on tablets by Hyland, a well-known maker of homeopathic products, revealed inconsistent amounts of belladonna, sometimes more than was listed on the label. The FDA asked Hyland to voluntarily recall its teething
8/18/17 - From Threat to Opportunity: Study Shows Cigarette Makers Shifted Stance on Nicotine Patches, Gum
The University of California's San Francisco campus issued the following news release:. "The industry has long taken a broad view of all nicotine products as a way to support smoking," said senior author Stanton Glantz, PhD, a UCSF professor of medicine and director of the UCSF Center for Tobacco Control Research and Education. " Our study shows t
8/18/17 - KONARED CORP - 10-Q - MANAGEMENTS' DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Certain information included herein contains forward-looking statements that involve risks and uncertainties within the meaning of Sections 27 A of the Securities Act, as amended; Section 21 E of the Securities Exchange Act of 1934. The factors that might cause such differences include, among others, the following: we have incurred significant loss
8/18/17 - Opioid Use Rarely Caused by Surgery Starts with Surgery Opioid Surgery Addiction HtkyLong-Term Opioid Use Rarely Starts with Surgery, Study Finds
Don t blame the nation s surgeons for an opiate-abuse crisis that now claims 142 lives daily in the United States. New research suggests that patients leaving the hospital after surgeries or inpatient procedures are rarely the ones whose long-term opioid use started with a doctor s prescription. Instead, the patients who most frequently go
8/18/17 - Patent Issued for Pharmaceutical Compositions and Methods of Use of 4-Pregenen-11.Beta.-17-21-Triol-3,20-Dione Derivatives (USPTO 9717743)
By a News Reporter-Staff News Editor at Drug Week ALLERGAN, INC. has been issued patent number 9717743, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Edelman, Jeffrey L.; Nehme, Alissar. This patent was filed on September 12, 2014 and was published online on August 1, 2017.
8/17/17 - Global OTC Pharmaceutical Market Forecast 2017-2027
Visiongain, a research firm, issued the following report:. The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127 bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceu
8/17/17 - Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog II Cream
Release date- 16082017- DUBLIN- Perrigo Company plc today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Mycolog II Cream. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Aff
8/16/17 - FDA Grants OTC Clearance for ABMC's Rapid TOX CUP II
American Bio Medica Corporation announced today that the U.S. Food and Drug Administration has granted 510 marketing clearance for over-the-counter use to the Company's Rapid TOX Cup II drug test product line. About American Bio Medica Corporation. American Bio Medica Corporation manufactures and markets accurate, cost-effective immunoassay test ki
8/16/17 - Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog II Cream
Perrigo Company plc today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Mycolog II Cream. Annual market sales for Mycolog II Cream for the 12 months ended June 2017 were approximately $93 million. Perrigo Company plc, a leading global healthc
8/15/17 - Innovus Pharmaceuticals Reports a Quarterly Net Revenue Increase of 99.2% and Net Loss Decrease of 74.1% Compared to the Same Period in 2016
Release date- 14082017- SAN DIEGO- Innovus Pharmaceuticals Inc. today announced second quarter 2017 net revenue of $2.0 million compared to $1.0 million in net revenue for the same period in 2016.. Net loss for the second quarter 2017 was $1.1 million compared to $4.4 million for the same period in 2016 and the net loss for the six months ended Jun
8/15/17 - Pharma companies eye US acquisition [China Daily: Africa Weekly]
Outbound Chinese pharmaceutical companies are consolidating their deployment in overseas markets, with both Fosun Pharma and Shanghai Pharmaceuticals eyeing the same acquisition target. According to the filings of the two companies respectively released on Monday, both Fosun Pharma and Shanghai Pharmaceuticals submitted non-binding proposals on...
8/15/17 - Pharmas vie over $3b US acquisition [China Daily: US Edition]
Outbound Chinese pharmaceutical companies are consolidating their deployment in overseas markets, with both Fosun Pharma and Shanghai Pharmaceuticals eyeing the same acquisition target. According to the filings of the two companies respectively released on Monday, both Fosun Pharma and Shanghai Pharmaceuticals submitted a non-binding proposal on...
8/14/17 - ACURA PHARMACEUTICALS, INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
This discussion and analysis should be read in conjunction with the Company's financial statements and accompanying notes included elsewhere in this Report. Historical operating results are not necessarily indicative of results in future periods. with Oxford Finance LLC, or to obtain a waiver from Oxford Finance LLC for our.
8/14/17 - For cosmetics, let the buyer beware
To be sure, these products are not nearly as worrisome as drugs, which require extensive testing and premarket approval by the Food and Drug Administration. Robert M. Califf, who served as FDA chief under President Barack Obama, noted, The cosmetic industry remains largely self-regulated. The FDA normally receives about 300 to 400 complaints a y
8/14/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 35965) - Webinar
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting by webinar to provide a status update on the process of FDA and industry discussions on an Over-the-Counter Monograph user fee program that began in July 2016.
8/14/17 - INNOVUS PHARMACEUTICALS, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Innovus Pharmaceuticals, Inc., together with its subsidiaries, are collectively referred to as "Innovus", the "Company", "us", "we", or "our". The following information should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this report. For additional context with which to underst
8/14/17 - INTRICON CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Headquartered in Arden Hills, Minnesota, IntriCon Corporation is an international company engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. In addition to its operations in Minnesota, the Company has facilities in Illinois, Singapore, Indonesia, Germany and the United Kingdom. The Company sold the card
Articles(s): 1 - 19 of 19     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415